For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit VaccineTogetherNY.org.
Dr. Art Sedrakyan provides commentary on a study, published in JACC: Cardiovascular Interventions, which found that transcatheter aortic valve replacement (TAVR) procedure is cheaper than the surgical alternative, despite falling reimbursements for the procedure.
